BCM
AMAG

BBT Capital Management’s AMAG Pharmaceuticals AMAG Stock Holding History

BBT Capital Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-23,612
Closed -$753K – 265
2014
Q3 		$753K Sell
23,612
-126,388
-84% -$2.69M 0.04% 223
2014
Q2 		$3.11M Buy
+150,000
New +$2.77M 0.19% 122

Other funds holding AMAG

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
GCM
Greywolf Capital Management Purchase, New York $67.3M AUM 100.05% 1-Year Est. Return

BBT Capital Management's AMAG Position: Q4 2014 in Review

BBT Capital Management sold out of AMAG Pharmaceuticals (AMAG) in Q4 2014, closing a stake of 23,612 shares — an estimated $753K sold.

BBT Capital Management first reported a position in AMAG in Q2 2014 and held it in 2 quarters. The position peaked at $3.11M in Q2 2014. 154 funds tracked by Wall St. Rank hold AMAG as of Q4 2014.

  • BBT Capital Management reported no remaining AMAG Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • BBT Capital Management sold 23,612 AMAG Pharmaceuticals shares in Q4 2014, an estimated $753K.
  • BBT Capital Management first reported a position in AMAG Pharmaceuticals in Q2 2014 and held it in 2 quarters.
  • BBT Capital Management's AMAG Pharmaceuticals position peaked at $3.11M in Q2 2014.
  • 154 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2014.

Based on BBT Capital Management's 13F filing for Q4 2014, filed 10 Feb 2015.